Estrategias Combinadas en Inmunoterapia Traslacional
ITC
National Institute of Allergy and Infectious Diseases
Bethesda, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von National Institute of Allergy and Infectious Diseases (1)
2021
-
DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type i conventional dendritic cells
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 5